-+ 0.00%
-+ 0.00%
-+ 0.00%

Capricor Therapeutics shareholders reject officer exculpation charter amendment at annual meeting

PUBT·06/08/2026 20:06:11
Listen to the news
Capricor Therapeutics shareholders reject officer exculpation charter amendment at annual meeting
  • Capricor Therapeutics held its annual shareholder meeting on June 4, 2026.
  • Shareholders ratified Rose, Snyder & Jacobs LLP as independent registered accounting firm for the fiscal year ending Dec. 31, 2026.
  • Shareholders did not approve an amendment to the certificate of incorporation on officer exculpation.
  • Shareholders voted to hold future advisory votes on named executive officer pay every year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capricor Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-071364), on June 08, 2026, and is solely responsible for the information contained therein.